Immuneering Corporation (IMRX)
- Previous Close
1.4300 - Open
1.4300 - Bid 1.4600 x 400
- Ask 1.4900 x 400
- Day's Range
1.4300 - 1.5100 - 52 Week Range
1.4000 - 11.9200 - Volume
294,601 - Avg. Volume
707,925 - Market Cap (intraday)
43.59M - Beta (5Y Monthly) -0.89
- PE Ratio (TTM)
-- - EPS (TTM)
-1.8800 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
13.29
Immuneering Corporation, a clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor currently under Phase 1/2a clinical trial to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 is in Investigational New Drug application to treat solid tumors. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts.
immuneering.comRecent News: IMRX
Performance Overview: IMRX
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: IMRX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: IMRX
Valuation Measures
Market Cap
43.59M
Enterprise Value
-37.61M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
0.48
Enterprise Value/Revenue
191.91k
Enterprise Value/EBITDA
0.65
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-32.46%
Return on Equity (ttm)
-53.36%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-53.47M
Diluted EPS (ttm)
-1.8800
Balance Sheet and Cash Flow
Total Cash (mrq)
85.67M
Total Debt/Equity (mrq)
4.93%
Levered Free Cash Flow (ttm)
-31.1M
Research Analysis: IMRX
Company Insights: IMRX
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: IMRX
Daily – Vickers Top Insider Picks for 04/26/2024
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 04/25/2024
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 04/24/2024
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 04/23/2024
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.